The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Three-Field Lymphadenectomy for Carcinoma of the Esophagus and Gastroesophageal Junction in 174 R0 Resections: Impact on Staging, Disease-Free Survival, and Outcome: A Plea for Adaptation of TNM Classification in Upper-Half Esophageal Carcinoma
Open accessAbstract
In Brief Objective: To determine the impact of esophagectomy with 3-field lymphadenectomy on staging, disease-free survival, and 5-year survival in patients with carcinoma of the esophagus and gastroesophageal junction (GEJ). Background: Esophagectomy with 3-field lymphadenectomy is mainly performed in Japan. Data from Western experience with 3-field lymphadenectomy are scarce and dealing with relatively small numbers. As a result, its role in the surgical practice of cancer of the esophagus and GEJ remains controversial. Methods: Between 1991 and 1999, primary surgery with 3-field lymphadenectomy was performed in 192 patients, of whom a cohort of 174 R0 resections was used for further analysis. Results: Hospital mortality of the whole series was 1.2%. Overall morbidity was 58%. Pulmonary complications occurred in 32.8%, cardiac dysrhythmias in 10.9%, and persistent recurrent nerve problems in 2.6%. pTNM staging was as follows: stage 0, 0.6%; stage I, 9.2%; stage II, 27.6%; stage III, 28.7%; and stage IV, 33.9%. Overall 3- and 5-year survival was 51% and 41.9%, respectively. The 3- and 5-year disease-free survival was 51.4% and 46.3%, respectively. Locoregional lymph node recurrence was 5.2%; no patient developed an isolated cervical lymph node recurrence. Five-year survival for node-negative patients was 80.2% versus 24.5% for node-positive patients. Five-year survival by stage was 100% in stages 0 and I, 59.1% in stage II, 36.8% in stage III, and 13.3% in stage IV. Twenty-three percent of the patients with adenocarcinoma (25.8% distal third and 17.6% GEJ) and 25% of the patients with squamous cell carcinoma (26.2% middle third) had positive cervical nodes resulting in a change of pTNM staging specifically related to the unforeseen cervical lymph node involvement in 12%. Cervical lymph node involvement was unforeseen in 75.6% of patients with cervical nodes at pathologic examinations. Five-year survival for patients with positive cervical nodes was 27.7% for middle third squamous cell carcinoma. For distal third adenocarcinomas, 4-year survival was 35.7% and 5-year survival 11.9%. No GEJ adenocarcinoma with positive cervical nodes survived for 5 years. Conclusions: Esophagectomy with 3-field lymph node dissection can be performed with low mortality and acceptable morbidity. The prevalence of involved cervical nodes is high, regardless of the type and location of tumor resulting in a change of final staging specifically related to the cervical field in 12% of this series. Overall 5-year and disease-free survival after R0 resection of 41.9% and 46.3%, respectively, may indicate a real survival benefit. A 5-year survival of 27.2% in patients with positive cervical nodes in middle third carcinomas indicates that these nodes should be considered as regional (N1) rather than distant metastasis (M1b) in middle third carcinomas. These patients seem to benefit from a 3-field lymphadenectomy. The role of 3-field lymphadenectomy in distal third adenocarcinoma remains investigational. Three-field lymphadenectomy was performed in 192 patients. R0 resection was obtained in 174 patients. Twenty-five percent (41 of 174) had cervical lymph node involvement resulting in a TNM change (stage IV) in 12%. Overall 5-year survival was 41.9%, being 80% for lymph node-negative patients (n = 52). Locoregional lymph node recurrence occurred in 5.2% of the patients (n = 9), distant metastasis in 28.5% (n = 49), and both locoregional lymph node recurrence and distant metastasis in 10% (n = 17). Patients with middle third squamous cell carcinoma had a 5-year survival of 27%. Cervical lymph node involvement in these patients should be classified as regional lymph node involvement (N1) and not as distant lymph node disease (M1b).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Radical Lymph Node Dissection for Cancer of the Thoracic Esophagus
Akiyama, H., Tsurumaru, M., Udagawa, H., & Kajiyama, Y. (1994) · Annals of Surgery · doi:10.1097/00000658-199409000-00012 · Cited by 901
Fujita, H., Kakegawa, T., Yamana, H., Shima, I., Toh, Y., Tomita, Y., Fujii, T., Yamasaki, K., Higaki, K., Noake, T., et al. (1995) · Annals of Surgery · doi:10.1097/00000658-199511000-00008 · Cited by 396
Surgical Strategies in Esophageal Carcinoma With Emphasis on Radical Lymphadenectomy
LERUT, T., LEYN, P. D., COOSEMANS, W., RAEMDONCK, D. V., SCHEYS, I., & LESAFFRE, E. (1992) · Annals of Surgery · doi:10.1097/00000658-199211000-00010 · Cited by 311
Self-citationTranshiatal esophagectomy for benign and malignant disease
Orringer, M. B., Marshall, B., & Stirling, M. C. (1993) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)33811-5 · Cited by 301
Nishihira, T., Hirayama, K., & Mori, S. (1998) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)00227-4 · Cited by 286
Evaluation of neck lymph node dissection for thoracic esophageal carcinoma
Kato, H., Watanabe, H., Tachimori, Y., & Iizuka, T. (1991) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(91)91008-j · Cited by 268
Autopsy Findings in Patients After Curative Esophagectomy for Esophageal Carcinoma
Katayama, A., Mafune, K., Tanaka, Y., Takubo, K., Makuuchi, M., & Kaminishi, M. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00116-9 · Cited by 43
Cited by
Pennathur, A., Gibson, M. K., Jobe, B. A., & Luketich, J. D. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60643-6 · Cited by 2,390
Stein, H. J., Feith, M., Bruecher, B. L. D. M., Naehrig, J., Sarbia, M., & Siewert, J. R. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000184211.75970.85 · Cited by 443
van Manen, L., Handgraaf, H. J. M., Diana, M., Dijkstra, J., Ishizawa, T., Vahrmeijer, A. L., & Mieog, J. S. D. (2018) · Journal of Surgical Oncology · doi:10.1002/jso.25105 · Cited by 322
Metadata
- Authors
- Lerut, T., Nafteux, P., Moons, J., Coosemans, W., Decker, G., De Leyn, P., Van Raemdonck, D., & Ectors, N.
- Venue
- Annals of Surgery
- Published
- 2004-12
- Volume
- 240
- Issue
- 6
- Pages
- 962-974
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W1996858090
- Cited by
- 376
- References
- 10
- FWCI
- 14.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Three-Field Lymphadenectomy for Carcinoma of the Esophagus and Gastroesophageal Junction in 174 R0 Resections: Impact on Staging, Disease-Free Survival, and Outcome: A Plea for Adaptation of TNM Classification in Upper-Half Esophageal Carcinoma. https://app.cochat.ai/papers/10.1097/01.sla.0000145925.70409.d7
- The paper
- Lerut, T., Nafteux, P., Moons, J., Coosemans, W., Decker, G., De Leyn, P., Van Raemdonck, D., & Ectors, N. (2004). Three-Field Lymphadenectomy for Carcinoma of the Esophagus and Gastroesophageal Junction in 174 R0 Resections: Impact on Staging, Disease-Free Survival, and Outcome: A Plea for Adaptation of TNM Classification in Upper-Half Esophageal Carcinoma. Annals of Surgery. https://doi.org/10.1097/01.sla.0000145925.70409.d7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.